Logo image
Cobalt Plaque Therapy of Posterior Uveal Melanomas
Journal article   Peer reviewed

Cobalt Plaque Therapy of Posterior Uveal Melanomas

Jerry A Shields, James J Augsburger, Luther W Brady, John L Day and Oncology Service, Wills Eye Hospital, Thomas Jefferson University, Philadelphia
Ophthalmology (Rochester, Minn.), v 89(10), pp 1201-1207
Oct 1982
PMID: 7155529

Abstract

choroidal melanoma cobalt plaque enucleation eye melanoma radiotherapy
One hundred patients with choroidal melanomas who were treated by the authors with cobalt plaque radiotherapy were analyzed with regard to tumor regression, visual results, complications, and mortality rate. The follow-up period at the time of this writing ranged from one to five years. These preliminary observations indicate that cobalt plaque radiotherapy induces tumor regression in 96% of cases, preserves useful vision in many cases and has fewer complications during the one- to five-year follow-up period than previously believed.

Metrics

6 Record Views
148 citations in Scopus

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Collaboration types
Domestic collaboration
Web of Science research areas
Ophthalmology
Logo image